Alloza, C. http://orcid.org/0000-0002-2092-8055
Blesa-Cábez, M.
Bastin, M. E.
Madole, J. W. http://orcid.org/0000-0002-2301-0004
Buchanan, C. R.
Janssen, J.
Gibson, J. http://orcid.org/0000-0002-3745-8360
Deary, I. J.
Tucker-Drob, E. M.
Whalley, H. C. http://orcid.org/0000-0002-4505-8869
Arango, C.
McIntosh, A. M. http://orcid.org/0000-0002-0198-4588
Cox, S. R. http://orcid.org/0000-0003-4036-3642
Lawrie, S. M. http://orcid.org/0000-0002-2444-5675
Article History
Received: 22 October 2019
Revised: 11 March 2020
Accepted: 25 March 2020
First Online: 27 April 2020
Conflict of interest
: C.A. has been a consultant to or has received honoraria or grants from Acadia, Angelini, Gedeon Richter, Janssen Cilag, Lundbeck, Otsuka, Roche, Sage, Servier, Shire, Schering Plough, Sumitomo Dainippon Pharma, Sunovion, and Takeda. In the last 3 years, S.M.L. has received research support from Janssen, and personal fees from Janssen and Sunovion. A.M.M. has previously received financial support from Janssen and Lilly. A.M.M., H.C.W., and S.M.L. have previously received financial support from Pfizer (formerly Wyeth) in relation to imaging studies of people with schizophrenia and bipolar disorder. All other authors report no biomedical financial interests or potential conflicts of interest.